Old Web
English
Sign In
Acemap
>
authorDetail
>
Gregory Bergonio
Gregory Bergonio
Cancer
Population
Antibody-drug conjugate
Trastuzumab
Regimen
2
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Reversible HER2 antibody-drug conjugate-induced ocular toxicity.
2021
Canadian Journal of Ophthalmology-journal Canadien D Ophtalmologie
Anushree Sharma
Kamran M. Riaz
Mohsain S. Gill
Amita Patnaik
Susanna Ulahannan
Judy Sing-Zan Wang
Dan S. Gombos
Qiuqing Ang
Dragan Cicic
Gregory Bergonio
Cong Zhang
Barbara M. Wirostko
Show All
Source
Cite
Save
Citations (0)
Abstract B005: A phase I study of A166, a novel anti-HER2 antibody-drug conjugate (ADC), in patients with locally advanced/metastatic solid tumors
2019
Molecular Cancer Therapeutics
Diana Lopez
Minal Barve
Judy Sing-Zan Wang
Andrea J. Bullock
Eirini Pectasides
Ulka N. Vaishampayan
Alexander I. Spira
Susanna Varkey Ulahannan
Amita Patnaik
Rachel E. Sanborn
Dragan Cicic
Qiuqing Ang
Gregory Bergonio
Jordi Rodon Ahnert
Show All
Source
Cite
Save
Citations (3)
1